Clinical Trials

93 enrolled

Fatigue, Hematologic Neoplasms

NCT05716919 2023-10-23

Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

32 enrolled

Fibrosis, Hematologic Neoplasms

NCT05510089 2023-10-10

Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

62 enrolled

Hematologic Neoplasms

NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

OtherOther hematologic neoplasm

110 enrolled

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

168 enrolled

Hematologic Neoplasms

NCT05460013 2023-08-01

Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation

100 enrolled

Body Weight, Hematologic Neoplasms

NCT05690425 2023-07-24

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

13 enrolled

Hematologic Neoplasms

NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Hematologic Neoplasms

NCT03806764 2023-06-01

CReSCT

370 enrolled

Cytomegalovirus Infections, Virus Diseases, Hematologic Neoplasms

NCT05808296 2023-04-11

The Effect of Lavender Oil on Fatigue and Sleep Quality

100 enrolled

Fatigue, Patient Participation, Sleep Wake Disorders, Hematologic Neoplasms

NCT05759975 2023-03-08

Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT

42 enrolled

Stomatitis, Xerostomia, Hematologic Neoplasms

NCT04809181 2023-02-21

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

95 enrolled

Recurrence, Hematologic Neoplasms

NCT04280133 2023-01-26

CAR T-CELL Therapy Educational Video Trial

80 enrolled

Hematologic Neoplasms

NCT05672420 2023-01-05

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

181 enrolled

Anemia, Hemorrhage, Infections, Leukemia, Lymphoma, Multiple Myeloma, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05610202 2022-11-09

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

137 enrolled

Hematologic Neoplasms

NCT05609227 2022-11-08

Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation

36 enrolled

Hematologic Neoplasms

NCT05602051 2022-11-01

Mindfulness-based Virtual Reality Intervention

110 enrolled

Hematologic Neoplasms

NCT05413356 2022-10-19

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

50 enrolled

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT05489276 2022-08-05

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

180 enrolled

Hematologic Neoplasms

NCT03373656 2022-07-26

Vaccination for Children of H&O and Their Parents

300 enrolled

Immunologic Deficiency Syndromes, Hematologic Neoplasms

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

LymphoidOther hematologic neoplasm

24 enrolled

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05445765 2022-07-06

Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia

10 enrolled

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

340 enrolled

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms

NCT04632316 2022-06-21

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

33 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

50 enrolled

COVID-19, Hematologic Neoplasms

NCT05364359 2022-05-06

HCP

40 enrolled

Neoplasms, Hematologic Neoplasms

NCT04327583 2022-04-28

IPPACTTO

396 enrolled

Neoplasm Metastasis, Patient Satisfaction, Hematologic Neoplasms

NCT04082910 2022-04-13

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

30 enrolled

Cytokine Release Syndrome, Hematologic Neoplasms

NCT05001386 2022-03-17

ESAAC

LymphoidMyeloidOther hematologic neoplasmPlasma cell

800 enrolled

Hypersensitivity, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Hematologic Neoplasms

NCT05250362 2022-03-15

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

56 enrolled

Recurrence, Hematologic Neoplasms

NCT05158608 2022-01-11

CY25

100 enrolled

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Phase 2/3 Unknown

180 enrolled

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03821519 2021-12-23

Haplo-CIK

Hematologic Neoplasms

NCT05084027 2021-10-27

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

50 enrolled

Hematologic Neoplasms

NCT03146468 2021-09-23

NIVALLO

14 enrolled

Hematologic Neoplasms

NCT05020639 2021-09-21

A Study of TQB3820 in Patients With Hematological Malignancies

116 enrolled

Hematologic Neoplasms

NCT04622956 2021-09-14

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

47 enrolled

Graft vs Host Disease, Hematologic Neoplasms

NCT05028478 2021-08-31

A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

164 enrolled

Phase EARLY_PHASE1 Unknown

Neoplasm Metastasis, Hematologic Neoplasms

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03083327 2021-04-28

Prophylactic Early PN in HPT/BMT

408 enrolled

Hematologic Neoplasms

NCT04854681 2021-04-22

Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers

Hematologic Neoplasms

NCT04412577 2021-04-01

A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies

57 enrolled

Hematologic Neoplasms

NCT04822974 2021-03-30

TTV-CART